Exposure to environmental agents can cause *de novo* mutations in the germline, leading to concerns over the genetic health of future generations (recently reviewed in [@kfw088-B9]). Extensive evidence suggests that the majority of *de novo* mutations arise in the male germline ([@kfw088-B6]; [@kfw088-B7]; [@kfw088-B19]; [@kfw088-B34]). Thus, there is a need to characterize the mutagenicity of environmental agents in male germ cells. The Organization for the Economic Co-operation and Development (OECD) Test Guideline for transgenic rodent (TGR) mutation assay (TG 488) is an internationally endorsed method ([@kfw088-B29]) that can be used to quantify induced mutations in somatic tissues and male germ cells ([@kfw088-B20]; [@kfw088-B27]; [@kfw088-B42]). Of critical importance is the ability to detect mutations in spermatogonial stem cells because these cells can permanently and continuously produce sperm that carry mutations.

In the mouse, mutations fixed in spermatogonial stem cells can be detected in sperm collected from the cauda epididymis at least 49 days after exposure to a mutagen ([@kfw088-B27]). This provides sufficient time for exposed stem cells to replicate and daughter cells to progress through spermatogenesis before they are collected as mature sperm. In practice, longer sampling times (ie, 70 days) are preferable to account for pharmacokinetic distribution of the mutagen after an exposure, and to allow stem cells to go through several rounds of replication while being exposed. Although stem cells are critical for detecting permanent effects, differentiated spermatogonia may be more sensitive to mutagens, as they divide more rapidly than stem cells ([@kfw088-B8]). Mutations fixed in dividing spermatogonia can be detected in cauda sperm approximately 35--42 days after they are induced. Thus, adjusting the sampling time between mutagen exposure and sperm collection allows the detection of induced mutations in specific germ cell populations.

The sampling times required to detect spermatogonial stem cell mutations in sperm are longer than what is generally recommended for measuring somatic mutation using the TGR assay. TG488 recommends a 28-day exposure period followed by a 3-day sampling time (28 + 3) for measuring mutations in somatic tissues ([@kfw088-B29]). Cauda sperm collected using this sampling time are derived from cells that were in the later phases of spermatogenesis during the exposure period. As germ cells progress through spermatogenesis they progressively lose their DNA repair capacity, and no longer replicate DNA ([@kfw088-B1]; [@kfw088-B14]; [@kfw088-B24]; [@kfw088-B31]; [@kfw088-B41]). Because errors in these processes are the primary mechanism of mutation fixation, post-meiotic germ cells are not sensitive to the induction of mutations that can be detected with the TGR assay, although they represent a sensitive window for the induction of lesions that may result in adverse effects after fertilization ([@kfw088-B23]). As a possible compromise, TG488 recommends collecting germ cells at the 3-day sampling time from the seminiferous tubules. However, cells from the seminiferous tubules represent a mixed population not adequately exposed as stem cells and are enriched for post-meiotic germ cells. Therefore, it is presently unknown whether the analysis of cells from seminiferous tubules provides the same sensitivity to detect germ cell mutagens as the analysis of sperm derived from exposed stem cells or dividing spermatogonia.

The mutagenic activity of benzo(a)pyrene (BaP), a ubiquitous environmental pollutant and Group 1 human carcinogen, has been extensively characterized for somatic tissues ([@kfw088-B15]; [@kfw088-B25]). BaP mutagenesis is less well-characterized in germ cells. BaP exposure via intraperitoneal (i.p.) injection induced dominant lethal mutations in meiotic and post-meiotic spermatogenic cells, but not heritable translocations ([@kfw088-B11]). Results for the specific locus test were negative or inconclusive for pre- and post-spermatogonial germ cells after i.p. injection ([@kfw088-B35]). Recent studies using TGR models have reported increases in the mutant frequencies (MF) of *lacZ* ([@kfw088-B39]) and *cII* reporter genes ([@kfw088-B30]) in mouse sperm collected 42 and 119 days after oral exposure to BaP, respectively. The latter increase was statistically significant compared with concurrent solvent-treated controls, but not significantly distinguishable from the MF in naïve animals. Thus, although BaP does induce mutations in male germ cells, the susceptibility of adult spermatogonial stem cells to BaP-induced mutation remains unclear.

Here, we characterize the dose response in germ cells of male transgenic mice (MutaMouse) exposed subchronically to BaP across various phases of spermatogenesis. We also compared the response in germ cells collected from the seminiferous tubules using a 28 + 3 experimental design with the response in cauda sperm collected at later sampling times to scrutinize the sensitivity of this design for detecting germ cell mutagenicity. Our results clarify the phase-specific sensitivity of male germ cells to the mutagenicity of BaP after subchronic oral exposure and provide important information on the ability to detect germ cell mutation at different sampling times.

MATERIALS AND METHODS
=====================

Exposures and tissue collection
-------------------------------

All protocols involving animal use were approved by the Health Canada Ottawa Animal Care Committee. Experiments were designed based on the OECD guideline TG488 ([@kfw088-B29]) and conducted as described previously ([@kfw088-B27]). We used MutaMouse transgenic mice, which are derived from a DBA2 and BALB/c cross (originally obtained from Covance Laboratories, Ltd., and maintained at in-house colony of for \>25 years), and harbor ∼29 tandem copies of a recombinant λgt10 phage vector on each copy of chromosome 3 ([@kfw088-B36]). The recombinant phage vector contains a mutation-reporting *Escherichia coli lacZ* gene. Male MutaMouse mice (8--10 weeks old, *n* = 5--6 per treated group, 8--12 for controls) were orally exposed to an olive oil vehicle control or 12.5, 25, 50, or 100 mg/kg bw BaP (Sigma-Aldrich, Oakville, ON, Canada) dissolved in olive oil for 28 consecutive days via gavage (volume = 5 µl/g bw). Mice were euthanized by cervical dislocation under isofluorane anesthesia 3, 42, or 70 days after the end of the exposure to assess effects on post-spermatogonia, dividing spermatogonia, and spermatogonial stem cells, respectively. Control groups comprised about 10 animals to provide a robust spontaneous mutant frequency especially for the seminiferous tubules, which had not been previously examined in our lab.

Cauda epididymides were collected for all 3 time points, flash frozen in liquid nitrogen, and stored at −80 °C. Sperm were later collected from the cauda as described previously ([@kfw088-B27]). Briefly, cauda were defrosted, minced, and suspended in cold phosphate buffered saline. The suspension was filtered through a size 80 mesh filter (\#S3770, Sigma-Aldrich). Non-germ cells in the filtrate were lysed with sodium dodecyl sulfate and the unlysed sperm were collected by centrifugation. During method development, analysis by microscopy did not reveal any contaminating somatic cells following this lysis step ([@kfw088-B43]). Seminiferous tubule cells were extracted from freshly excised testes only for the 3-day post-exposure time-point as described previously ([@kfw088-B27]). Briefly, the epithelial capsule was removed from the testes to release the seminiferous tubules. Germ cells were extracted from the seminiferous tubules by squeezing the tubules in phosphate buffered saline using a tissue roller. Tubules were removed from the suspension by gravity sedimentation, and the remaining cells in suspension were collected by centrifugation, flash frozen in liquid nitrogen, and stored at −80 °C. [Table 1](#kfw088-T1){ref-type="table"} shows the type of germ cells targeted and the phases of spermatogenesis the target germ cells passed through during exposure for each time-point. TABLE 1Cell types and phases of spermatogenesis that are targeted by various experimental designs.Sampling time (days)TissuePhase at beginning of exposurePhases passed during exposurePhases passed after exposureCollected cell types3CaudaSpermatocyteSpermatocyteSpermSpermSpermatidSpermTubulesStem cellStem cellStem cell+ SpermatogoniaSpermatogoniaSpermatogoniaSpermatogonia ++ SpermatocyteSpermatocyteSpermatocyteSpermatocyte +++ SpermatidSpermatidSpermatid +++ Sperm42CaudaStem cellStem cellSpermatogoniaSpermSpermatogoniaSpermatocyteSpermatidSperm70CaudaStem cellStem cellStem cellSpermSpermatogoniaSpermatocyteSpermatidSperm[^2]

*LacZ* mutation assay
---------------------

Genomic DNA was isolated from cauda sperm and seminiferous tubule cells as described previously ([@kfw088-B27]). Germ cells were digested with proteinase K and β-mercaptoethanol (cauda sperm only). Genomic DNA was extracted using phenol/chloroform. The extracted DNA was concentrated by ethanol precipitation and stored at 4 °C in Tris-EDTA buffer, pH 8, then quantified using a NanoDrop spectrophotometer (Thermo Scientific).

The *lacZ* MF was determined in genomic DNA isolated from germ cells as previously described ([@kfw088-B27]). Briefly, λgt10 phage vectors were recovered from approximately 1 to 4 µg of DNA using Transpack Packaging Extract kits (Agilent Technologies, Mississauga, ON, Canada) according to the manufacturer's instructions. The *lacZ*^−^/*galE*^− ^*E. coli* were infected with the recovered phage and grown on agar containing 0.3% phenyl-β-[d]{.smallcaps}-galactopyranoside (P-Gal) to detect mutants, or on agar without P-Gal to determine the total number of plaque-forming units (pfu). A minimum of 125 000 total pfu were scored for each animal (average = 390 000 pfu). When necessary, plaque counts from multiple assays per animal, including some instances of reactions with zero mutant counts, were combined to achieve this minimal total pfu only if replicates did not fail a binomial likelihood ratio test (*P* \< .05).

The MF was calculated by dividing the number of mutant plaques by the total pfu count. The proportion of BaP induced mutants to total pfu was compared with the proportion in the control group by logistic regression using the glm function in R ([@kfw088-B33]) with a quasibinomial error distribution to account for overdispersion in the data. The resulting *P*-values were adjusted for multiple comparisons using a Bonferroni correction. Outlier samples (4 out of 137 samples: the cauda and tubules of one animal from the 28 + 3 25 mg/day had unusually high MF, as did one sample from the 42-day 25 mg/kg/day group and one sample from the 70-day control group) were removed from the analysis if their MF were significantly different from the other samples in the same dose group based on the above logistic regression. The highest dose of BaP that did not induce a statistically significant (*P* \< .05) change in MF over controls was identified as the no observable genotoxic effect level (NOGEL).

Dose-response modeling
----------------------

Characterization of the dose response was conducted following established approaches ([@kfw088-B13]; [@kfw088-B17]; [@kfw088-B28]). This analysis was only performed for time-points that displayed a significant increasing trend in MF with dose, based on the Cochrane Armitage test for trend. These data sets met the minimum recommended number of dose groups for this type of analysis, which is 5 groups including controls ([@kfw088-B17]). Dose-response modelling was performed using the U.S. Environmental Protection Agency's (EPA) Benchmark Dose Software (BMDS, v2.6.0.1). The BMDS variance likelihood ratio test (LRT) was used to select between a homogeneous or non-constant variance model. A dose--response model was then selected from the linear, quadratic, exponential, and power models based on the lowest Akaike Information Criterion (AIC). An additional goodness-of-fit LRT was used to assess the model fit. The benchmark response (BMR) was set to 10% of the control group above the estimated response of the model at dose = zero in order to determine the benchmark dose (BMD~10~) and its lower 90% confidence limit (BMDL~10~).

The "drsmooth" R package ([@kfw088-B17]) was used to assess additional characteristics of the dose--response relationship. We used the "linearity before cut-off dose" (lbcd) function to test whether the slope of the dose response before the identified NOGEL was significantly greater than zero (*P* \< .05). The "segmented" function was used to identify the dose at which the slope of a fitted bilinear model becomes greater than zero (the breakpoint dose, BPD) and its lower 95% confidence limit (BPDL). The "smooth" function was used to identify the point at which the slope of a fitted smoothing regression spline first became significantly greater than zero (the slope transition dose, STD) and its lower 95% confidence limit (STDL).

RESULTS
=======

BaP Exposures and *LacZ* Mutant Frequencies in Germ Cells
---------------------------------------------------------

MutaMouse males were treated by oral gavage with an olive oil vehicle control or with BaP (up to 100 mg/kg bw/day) for 28 consecutive days. Germ cells were collected from the cauda epididymis 3, 42 or 70 days after treatment, or from the seminiferous tubules 3 days after treatment. BaP treatment did not have a significant effect on testicular mass relative to body weight (data not shown). The *lacZ* MFs in BaP-exposed germ cells collected at various times are summarized in [Table 2](#kfw088-T2){ref-type="table"} and shown graphically in [Figure 1](#kfw088-F1){ref-type="fig"}. Plaque counts for each individual animal are shown in **[Supplementary Table 1](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfw088/-/DC1)**. The *lacZ* MF in cauda sperm collected 3 days after exposure was not significantly different from control levels for any dose group. The MFs in germ cells from the seminiferous tubules of testes collected at this time-point reached a maximum average of 6.4 × 10^−5^ (2.7-fold above concurrent controls) in the 100 mg/kg bw/day dose group. However, this increase in MF was not statistically significant (*P* = .35) compared with the control group due to the high variation in the treated group. Sperm collected from cauda 42 days post-exposure had a significant dose-dependent increase in MF that reached 13.1 × 10^−5^ (4.2-fold above controls) at 100 mg/kg bw/day. The other doses did not cause significant increases in MF at this time-point. Sperm collected from the cauda 70 days after exposure showed significant increases in both the 50 and 100 mg/kg bw/day dose groups, achieving a maximum induced MF of 5.3 × 10^−5^ (2.1-fold above controls) in the high dose group. At 100 mg/kg bw/day, the MF at 42 days was significantly higher (*P* \< .01) than all other time-points, including 70 days. Thus, BaP induced significant increases in MF in sperm exposed as dividing spermatogononia and spermatogonial stem cells, whereas no statistically significant increase was observed in cauda sperm cells or cells collected from seminiferous tubules 3 days post-exposure. FIG. 1*LacZ* mutant frequency (MF) dose response in spermatogenic cells exposed to benzo\[a\]pyrene: **A**, sperm collected from the cauda epididymis 3 days after a 28 day exposure; **B**, germ cells collected from the seminiferous tubules 3 days after exposure; **C**, sperm collected from the cauda epididymis 42 days after exposure; and **D**, sperm collected from the cauda epididymis 70 days after exposure. TABLE 2*LacZ* mutant frequency in male germ cells of Muta^TM^mouse mice exposed to benzo\[a\]pyrene for 28 days and collected at various sampling times.Sampling timeTissueDose (mg/kg/day)*n*\# mutants\# pfuAverage[^a^](#kfw088-TF2){ref-type="table-fn"} MF × 10^−5^SD[^a^](#kfw088-TF2){ref-type="table-fn"}*P*-value3Cauda0121384 446 6613.11.7--12.55141 066 3971.40.9.098725424913 6532.60.91.0000505331 101 6833.11.31.00001005873 669 1862.50.7.55393Tubules08512 194 2542.41.1--12.55521 452 4003.41.71.0000255381 449 0872.61.21.0000506852 173 0523.91.5.664510061022 341 2016.44.0.350142Cauda0111023 716 4023.12.5--12.56672 007 8793.30.81.0000255301 239 1882.40.61.00005061041 937 8025.42.5.073810054473 523 56413.13.4**\<.0001**70Cauda091305 118 6042.50.7--12.56753 095 9802.71.11.0000255652 261 6812.31.21.0000505861 842 3794.71.2**.0045**10051863 598 9435.31.2**.0001**[^3][^4][^5]

Dose--Response Modeling
-----------------------

Highly significant trends for increasing MF with dose were observed for all time-points (Cochrane Armitage test for trend, *P* \< .001), except for the 28 + 3 cauda sperm (*P* = .922). As such, the 28 + 3 cauda sperm data were omitted from further dose-response analysis. Dose--response data for all other data sets were modeled using the U.S. EPA BMDS software. Data were fit to 4 different dose--response models (linear, quadratic, exponential, or power models) each with 2 different variance models (constant or non-constant variance) for a total of 8 possible models. The best fitting model was selected for each time-point based on the lowest AIC score. The models selected for each time-point are shown graphically in [Figure 1](#kfw088-F1){ref-type="fig"}. Goodness-of-fit LRT *P*-values are shown in [Supplementary Table 2](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfw088/-/DC1). Only the data from the 42 day time-point had poor fit (*P* \< .05) for either variance model. This was not improved after applying a log or square-root transformation, which are often recommended ([@kfw088-B13]) (data not shown). Because none of the variance models in BMDS had ideal fits (*P* \> .1) for this data set, we used the constant variance model because it produced the lowest AIC value and best model fit *P*-value. The selected dose--response models showed acceptable fit (*P* \> .1) for all data sets. BMDs based on a 10% response were derived using the best fit models and are shown graphically in [Figure 1](#kfw088-F1){ref-type="fig"}, and with their 90% lower confidence limits in [Supplementary Table 2](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfw088/-/DC1). We also tested whether the slope of the dose response was significantly different from zero up to and including the NOGEL. Although no single dose group has a response that was significantly greater than controls for the tubules at 28 + 3, a statistically significant trend was observed, that was best described by the exponential model (and therefore not linear up to the NOGEL of 100 mg/kg bw/day), with a BMD~10~ of 10.4 mg/kg bw/day. Sperm from the 42-day time-point were best described by a polynomial dose response, with a BMD~10~ of 16.7 mg/kg bw/day. The slope of this dose response was not significantly different than zero up to the NOGEL of 50 mg/kg bw/day, although only marginally so (*P* = .053). The *lacZ* MF in the 70-day group was best described by an exponential dose response. The highest BMD~10~ (43.0 mg/kg bw/day) was found for this post-exposure time point. The slope of this dose response was also not significantly different than zero up to the NOGEL of 25 mg/kg bw/day (*P* = .752). A significant BPD and STD was only detected for the day 42 sperm data (shown graphically in [Figure 2](#kfw088-F2){ref-type="fig"}, and with their 95% lower confidence limits in [Supplementary Table 2](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfw088/-/DC1)). These values were 34.1 mg/kg bw/day and 22.1 mg/kg bw/day, respectively. The slopes of *lacZ* MF response in all 3 time points at which dose-dependent increases were observed (28 + 3 tubules, 42-day, and 70 day sperm) were not significantly different than zero up to and including 25 mg/kg bw/day (*P* \> .05). In summary, sperm derived from exposed dividing spermatogonia (42 days post-exposure) were more sensitive to BaP-induced mutation following subchronic oral exposure compared with sperm from exposed spermatogonial stem cells (based on BMD analysis). Despite having no single dose with a significantly elevated MF (based on logistic regression), a significant trend was observed (based on the Cochrane Armitage test) in germ cells from the 28 + 3 seminiferous tubules that was comparable to the trends observed in cauda sperm. Collectively, the dose-response analyses from all 3 of these data sets suggest that the mutational response in male germ cells to BaP is sub-linear in the low dose range. FIG. 2*LacZ* mutant frequency (MF) dose-response models used to determine: **A**, the breakpoint dose; and **B**, the slope transition dose for sperm collected 42 days after exposure to benzo\[a\]pyrene.

DISCUSSION
==========

We used the *lacZ* mutation assay to characterize the dose response of various phases of spermatogenesis in transgenic mice exposed subchronically to BaP. Our results demonstrate that BaP induces mutations in spermatogonial stem cells of adult mice, but that the strongest mutational effect is observed in dividing spermatogonia. Comparison of the response in germ cells collected from the seminiferous tubules 3 days after a 28 day exposure (MF ranging from 2.4 to 6.4 × 10^−5^) with that in cauda sperm collected 70 days after exposure (ranging from 2.5 to 5.3 × 10^−5^) shows that, although comparable MFs were obtained in the 2 systems, statistically significant effects were observed only in cauda sperm.

Our results strengthen the existing body of evidence that BaP is a spermatogonial stem cell mutagen in mice. We observed a dose-dependent increase in *lacZ* MF that was statistically significant at the 2 top dose groups (50 mg/kg bw/day and 100 mg/kg bw/day) in sperm collected 70 days after the end of the 28-day exposure. One study previously reported an increased MF in sperm of mice collected 119 days after 3 daily intraperitoneal (i.p.) exposures of 50 mg/kg bw BaP (150 mg/kg bw total) ([@kfw088-B30]). The stem cell effect was statistically significant when compared with concurrent solvent-treated controls, but not when compared with naïve animals. More definitive stem cell effects were observed in pre-pubescent mice exposed to BaP ([@kfw088-B40]); increased *lacI* MFs were observed in isolated pachytene spermatocytes, round spermatids, and spermatozoa collected 35 days after juvenile mice (7 days old) were exposed to a single i.p. injection of up to 300 mg/kg/bw BaP. This effect was less apparent in older mice (25 and 60 days old) using a similar experimental design, where significant effects were only detected in pachytene spermatocytes at the highest dose. These findings and the results from the present study collectively demonstrate that BaP is a spermatogonial stem cell mutagen in mice and that exposure to this chemical can permanently increase the production of mutated sperm throughout the reproductive life of the animal.

Dividing spermatogonia represent the most sensitive spermatogenic population to BaP-induced mutations following oral exposure. In fact, the MF for the highest BaP dose was significantly higher than that observed after stem cell exposure (*P* \< .01). An elevated MF was also detected at 50 mg/kg bw/day, but this was only marginally significant (*P* = .074), likely due to the unusually high variability in the control group at this time-point ([Table 2](#kfw088-T2){ref-type="table"}). The strong MF response observed at 42 days post-exposure correlates with the higher rate of division in dividing spermatogonia relative to spermatogonial stem cells ([@kfw088-B8]). In addition, it has been shown that there is approximately a one week delay in the formation of BaP-induced DNA adducts in sperm after an oral exposure ([@kfw088-B38]). Therefore, BaP may continue to be delivered to the testes several days after the final oral dose and additional mutations may have been produced during the last week of active spermatogonial divisions before the cells commit to meiosis. Dividing spermatogonia represent a sensitive window for induction for other types of genomic alterations such as tandem repeat mutations ([@kfw088-B3]; [@kfw088-B37]). Therefore, dividing spermatogonia may be the most useful spermatogenic population to determine whether a chemical is a germ cell mutagen.

Important data gaps exist on whether the analysis of cells from seminiferous tubules at the time-point commonly used for detecting mutations in somatic tissues (ie, 28 + 3) provides the same sensitivity to detect germ cell mutagens as the analysis of sperm derived from exposed spermatogonia ([@kfw088-B42]). As expected, we observed no change in the *lacZ* MF in cauda sperm collected at this time-point ([Figure 1](#kfw088-F1){ref-type="fig"}), which represent germ cells that were spermatocytes or spermatids during the exposure period. These cell types do not synthesize DNA and lose their DNA repair capacity, processes that are required to fix mutations ([@kfw088-B24]). They are also on the lumen (closed) side of the blood-testes barrier, which can differentially affect the distribution of toxicants to the various germ cell phases ([@kfw088-B42]). Conversely, the analysis of germ cells from seminiferous tubules at the 28 + 3 time point targets a mixture of cells with varying capacity for DNA synthesis and repair during exposure ([@kfw088-B24]; [@kfw088-B31]; [@kfw088-B41]). The MF obtained from seminiferous tubule cells were comparable with those observed in sperm collected 70 days after the end of exposure ([Table 2](#kfw088-T2){ref-type="table"}) and showed an apparent dose response ([Figure 1](#kfw088-F1){ref-type="fig"}). However, no statistically significant increase above controls was found. Similarly, [@kfw088-B39] detected a significant increase in plasmid-born *lacZ* MF in sperm collected 42 days after BaP exposure, but not in the testes at this same time point. The apparent signal suppression in the testes is likely due to the mixed nature of the exposed and sampled cell population, which contains germ cells from various phases of spermatogenesis that are enriched for post-meiotic germ cells, and a small amount of somatic (Leydig and Sertoli) cells. These non-target cells may dilute the mutational effect, thereby decreasing assay sensitivity. Therefore, simultaneously measuring induced mutations in somatic tissues and germ cells at 28 + 3 may not represent an optimal approach for detecting germ cell mutagens, especially weak mutagens. A time-point that would allow more cells exposed as dividing spermatogonia to be collected (eg, 28 + 28) may provide a stronger signal in the tubules.

Mutant frequency (MF) data from the TGR mutation assay often suffer from overdispersion (ie, greater variability than predicted by the theoretically binomial error distribution), which can negatively impact assay sensitivity. One of the primary causes of this increased variability is that the clonal expansion of mutations in some samples is greater than in others. This is of particular concern for control samples, where recovered mutations may have occurred before the experimental time-frame. Overdispersion can be accounted for, to a limited degree, during statistical analysis (for example, by assuming a quasi-binomial error distribution). Alternatively, assay sensitivity can be greatly improved by correcting the MF for clonality, which can only be done by sequencing the recovered mutants to quantify the degree of clonal expansion in each sample. Previously, such an endeavor would be rather costly and time-consuming, especially for the large *lacZ* gene. However, technological advances have made sequencing much more amenable to regulatory testing, and may soon make routine clonal correction of TGR MF data more practical ([@kfw088-B2]; [@kfw088-B4]).

Dose--response modeling showed that the BMD~10~ was lower in dividing spermatogonia than spermatogonial stem cells. Our result supports the previous observation that actively dividing germ cells are more susceptible to BaP-induced mutations than spermatogonial stem cells. These BMDs are higher (10.4--43.0 mg/kg bw/day in germ cells, present study) than what has been reported for mutation in somatic tissues (0.5--7.2 mg/kg bw/day, [@kfw088-B25]). The BMD~10~ of germ cells collected from the tubules was very similar to the BMD~10~ of dividing spermatogonia. However, caution should be used when interpreting the BMD~10~ derived from tubule cells, considering the mixed nature of the target cell population and the fact that significant effects were not detected at any dose tested. Differences in the pharmacokinetic distribution of BaP and its metabolites in the testes and somatic tissues may contribute to the variation in response. BPDE-DNA adducts are detected in somatic tissues and testes within days of exposure ([@kfw088-B21]; [@kfw088-B30]; [@kfw088-B38]). However, no studies have compared adduct levels between these tissues after the typical OECD-recommended 28-day exposure regimen. Such information would help clarify how much of the BaP metabolites reach the testes relative to other tissues, enabling comparison of mutagenic efficiency in these cell types. It is thought that germ cells in general may have superior resistance to spontaneous and environmentally induced mutation ([@kfw088-B26]), which may also have contributed to the reduced levels of BaP-induced mutation in sperm.

The findings from dose-response modelling suggest a sub-linear dose response for the induction of mutations by BaP after spermatogonial stem cell exposure. In fact, slope analysis in the low dose region of the curves indicated that the mutagenic effect of BaP did not have a slope significantly greater than zero at doses below 25 mg/kg bw/day for all cell types targeted. A significant BPD and STD were also identified at the 42-day time-point, further supporting a sub-linear response. There is increasing evidence for sub-linear dose responses for DNA reactive mutagens, such as ethyl methanesulfonate, and *N*-ethyl-*N*-nitrosourea in both somatic tissues and germ cells ([@kfw088-B5]; [@kfw088-B10]; [@kfw088-B12]; [@kfw088-B22]; [@kfw088-B28]; [@kfw088-B32]). This is indicative of a saturable repair response, where at lower doses the DNA damage is repaired, but repair processes are overwhelmed as doses increase ([@kfw088-B18]; [@kfw088-B44]). Because BaP induces mutations primarily through DNA adduct-forming metabolites, it is possible that the sub-linear dose response is attributable to a saturable repair mechanism for BaP adducts. Data with knockout mice suggest that nucleotide excision repair (NER) is essential to BaP-induced mutation ([@kfw088-B39]) and that NER activity varies among spermatogenic cell types ([@kfw088-B16]; [@kfw088-B41]).

In conclusion, we demonstrated that oral exposure to BaP causes spermatogonial stem cell mutations in mice and that dividing spermatogonia represent a window of peak sensitivity for the induction of mutations. Evaluation of MFs in cells from the cauda and seminiferous tubules at the time-point recommended in the OECD test guideline for measuring mutations in somatic tissues (28 + 3) may not be sufficiently sensitive to detect germ cell mutagens, suggesting that data derived from this design be interpreted with caution. We advise that a later time point after the exposure (eg, 28 days for tubules, 42 days for cauda sperm) provides a more sensitive measure of germ cell mutagenic response for chemical assessment.

SUPPLEMENTARY DATA
==================

[Supplementary data](http://toxsci.oxfordjournals.org/lookup/suppl/doi:10.1093/toxsci/kfw088/-/DC1) are available online at<http://toxsci.oxfordjournals.org/>.
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[^2]: + indicates the relative proportion of cell types when a mixture is collected.

[^3]: ^a^Average mutant frequency (MF) and standard deviation (SD) based on the arithmetic mean of individual animals.

[^4]: pfu: plaque forming units.
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